Burning Rock Biotech Limited BNR

Updated: 10 Aug 2026

NASDAQ | Biotech | Precision oncology and cancer diagnostics

No signal published yet

We already track Burning Rock Biotech and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Burning Rock Biotech free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Precision oncology and cancer diagnostics
We're already tracking Burning Rock Biotech Limited — here are the latest events we've registered

Recent News

  • On July 2, 2026, Burning Rock announced that founder and CEO Yusheng Han purchased 73,141 ADSs in the open market for approximately USD 618,000. The transaction was part of a series of share purchases conducted across three consecutive post-earnings trading windows.

What Firelda Watch includes for Burning Rock Biotech Limited

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Burning Rock Biotech Limited will be delivered in the same format.

Want to follow Burning Rock Biotech Limited? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Burning Rock Biotech free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Burning Rock Biotech Limited BNR
Burning Rock Biotech — follow and we'll monitor it
Follow Burning Rock Biotech free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.